TR200402454T4 - C-4 karbonat taksanlar. - Google Patents

C-4 karbonat taksanlar.

Info

Publication number
TR200402454T4
TR200402454T4 TR2004/02454T TR200402454T TR200402454T4 TR 200402454 T4 TR200402454 T4 TR 200402454T4 TR 2004/02454 T TR2004/02454 T TR 2004/02454T TR 200402454 T TR200402454 T TR 200402454T TR 200402454 T4 TR200402454 T4 TR 200402454T4
Authority
TR
Turkey
Prior art keywords
formula
compounds
taxanes
carbonate
zopropyl
Prior art date
Application number
TR2004/02454T
Other languages
English (en)
Turkish (tr)
Inventor
F. Kadow John
Mastalerz Harold
May Xue Qiufen
Hansel Steven
Edson Zoeckler Mary
C. Rose William
G. Tarrant James
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of TR200402454T4 publication Critical patent/TR200402454T4/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Carbon And Carbon Compounds (AREA)
TR2004/02454T 2000-02-03 2000-11-16 C-4 karbonat taksanlar. TR200402454T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17996500P 2000-02-03 2000-02-03

Publications (1)

Publication Number Publication Date
TR200402454T4 true TR200402454T4 (tr) 2004-12-21

Family

ID=22658728

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02454T TR200402454T4 (tr) 2000-02-03 2000-11-16 C-4 karbonat taksanlar.

Country Status (20)

Country Link
US (1) US6750246B1 (enExample)
EP (1) EP1251846B1 (enExample)
JP (1) JP2003523971A (enExample)
AT (1) ATE273005T1 (enExample)
AU (1) AU778284B2 (enExample)
CA (1) CA2399116A1 (enExample)
CZ (1) CZ20022956A3 (enExample)
DE (1) DE60012988T2 (enExample)
DK (1) DK1251846T3 (enExample)
ES (1) ES2226954T3 (enExample)
HK (1) HK1047891B (enExample)
MY (1) MY129310A (enExample)
NZ (1) NZ521136A (enExample)
PE (1) PE20020747A1 (enExample)
PT (1) PT1251846E (enExample)
RU (1) RU2243223C2 (enExample)
TR (1) TR200402454T4 (enExample)
TW (2) TWI245042B (enExample)
WO (1) WO2001056565A1 (enExample)
ZA (1) ZA200207037B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916942B2 (en) * 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
UY27185A1 (es) * 2001-02-28 2002-09-30 Bristol Myers Squibb Co Dosificación metronómica de taxanos
EP1623706A3 (en) * 2001-02-28 2006-02-22 Bristol-Myers Squibb Company Metronomic dosing of taxanes for inhibiting tumor growth
US7063977B2 (en) * 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
CA2470826A1 (en) * 2001-12-20 2003-07-03 Bristol-Myers Squibb Company Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
US20070105944A1 (en) * 2002-10-25 2007-05-10 Comezoglu S N Taxane metabolites
US7371759B2 (en) * 2003-09-25 2008-05-13 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
TW200533339A (en) * 2004-03-16 2005-10-16 Bristol Myers Squibb Co Therapeutic synergy of anti-cancer compounds
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
TW200538453A (en) * 2004-04-26 2005-12-01 Bristol Myers Squibb Co Bicyclic heterocycles as kinase inhibitors
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US20050288290A1 (en) 2004-06-28 2005-12-29 Borzilleri Robert M Fused heterocyclic kinase inhibitors
US7439246B2 (en) * 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
WO2006058121A1 (en) * 2004-11-23 2006-06-01 Bristol-Myers Squibb Company Crystalline forms of 3'-tert-butyl-3'-n-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-n-debenzoyl-4-o-methoxycarbonyl-paclitaxel
US20060258736A1 (en) * 2005-05-12 2006-11-16 Bristol-Myers Squibb Company Dosing regimen
US20080221135A1 (en) * 2005-05-13 2008-09-11 Bristol-Myers Squibb Company Combination therapy
US7348325B2 (en) 2005-11-30 2008-03-25 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
PL217731B1 (pl) 2006-06-01 2014-08-29 Tomasz Byrski Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi
MX352661B (es) 2009-11-05 2017-12-04 Rhizen Pharmaceuticals S A Star Moduladores novedosos de benzopiran cinasa.

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110249A (en) 1989-05-31 1998-03-31 Univ Florida State Method for preparation of taxol using beta lactam
US5284864A (en) 1991-09-23 1994-02-08 Florida State University Butenyl substituted taxanes and pharmaceutical compositions containing them
US5399726A (en) 1993-01-29 1995-03-21 Florida State University Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US6521660B2 (en) 1991-09-23 2003-02-18 Florida State University 3′-alkyl substituted taxanes and pharmaceutical compositions containing them
US6335362B1 (en) 1991-09-23 2002-01-01 Florida State University Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
FR2698871B1 (fr) * 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
HU0203995D0 (en) 1992-12-23 2003-04-28 Bristol Myers Squibb Co Oxazole derivatives for synthesis of sidechain-bearing taxanes and preparation thereof
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US5567592A (en) 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
CA2192373A1 (en) 1994-06-09 1995-12-14 Hirofumi Terasawa Deacetoxytaxol derivative
FR2721024B1 (fr) * 1994-06-09 1996-07-12 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2726272B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US5840929A (en) 1995-04-14 1998-11-24 Bristol-Myers Squibb Company C4 methoxy ether derivatives of paclitaxel
TW354293B (en) 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US6964946B1 (en) 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
US6245805B1 (en) 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US5739359A (en) * 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
HUP0101457A3 (en) 1997-12-31 2003-01-28 Bristol Myers Squibb Co Antitumor 2-aroyl-4-acyl paclitaxel analogs and medicaments containing them , their intermediates and method for producing them
KR100648125B1 (ko) 1999-05-17 2006-11-24 브리스톨-마이어스스퀴브컴파니 파클리탁셀 (탁솔 (Taxol, 등록상표)) 및 파클리탁셀유사체 제조에서 실릴 에테르의 절단을 위한 신규 반응조건
ATE266015T1 (de) 1999-08-11 2004-05-15 Bristol Myers Squibb Co Verfahren zur herstellung eines c-4- methylcarbonat-analogons von paclitaxel
BR0015149A (pt) 1999-10-27 2002-10-29 Baker Norton Pharma Método e composições para administração de taxanos oralmente a pacientes humanos
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
NZ539046A (en) 2001-01-18 2006-11-30 Pharmacia & Upjohn Co Llc Chemotherapeutic self-emulsifying microemulsion compositions of paclitaxel with improved oral bioavailability
UY27185A1 (es) 2001-02-28 2002-09-30 Bristol Myers Squibb Co Dosificación metronómica de taxanos
DE10154464B4 (de) 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
AU2002357012A1 (en) 2001-11-27 2003-06-10 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof

Also Published As

Publication number Publication date
PT1251846E (pt) 2004-11-30
JP2003523971A (ja) 2003-08-12
CA2399116A1 (en) 2001-08-09
DK1251846T3 (da) 2004-11-29
RU2002123641A (ru) 2004-01-10
DE60012988D1 (en) 2004-09-16
AU1769201A (en) 2001-08-14
HK1047891A1 (en) 2003-03-14
AU778284B2 (en) 2004-11-25
HK1047891B (en) 2005-01-28
RU2243223C2 (ru) 2004-12-27
US6750246B1 (en) 2004-06-15
ES2226954T3 (es) 2005-04-01
TWI245041B (en) 2005-12-11
TW200526613A (en) 2005-08-16
TWI245042B (en) 2005-12-11
ZA200207037B (en) 2003-12-02
MY129310A (en) 2007-03-30
EP1251846B1 (en) 2004-08-11
EP1251846A4 (en) 2003-03-12
ATE273005T1 (de) 2004-08-15
DE60012988T2 (de) 2005-08-25
EP1251846A1 (en) 2002-10-30
CZ20022956A3 (cs) 2003-02-12
PE20020747A1 (es) 2002-08-17
WO2001056565A1 (en) 2001-08-09
NZ521136A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
TR200402454T4 (tr) C-4 karbonat taksanlar.
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
DE60144392D1 (de) Antivirale mittel
DE60330407D1 (de) Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
DE60324155D1 (de) Indol-3-carbinol metaboliten als chemotherapeutische und chemopräventive wirkstoffen
CO5590918A2 (es) Formulaciones
CY1107939T1 (el) Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητη
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
TR200402529T4 (tr) Yeni Fenalliloksi fenil türevleri.
DE60120427D1 (de) Radicicol und monocillin und ihre analogen und ihre anwendungen
ATE498600T1 (de) Inden derivate als pharmazeutika
DE60005517D1 (de) Kaliumkanal-blockierende mittel
ATE284882T1 (de) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
BR0014687A (pt) Compostos de taxano pentacìclico
AR025380A1 (es) Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus.
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
DE60119514D1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure
BR0211762A (pt) Certos policetìdeos substituìdos, composições farmacêuticas contendo os mesmos e seu uso no tratamento de tumores
EA200000261A3 (ru) Новые замещенные димерные соединения, способ их получения и содержащияся их фармацевтическая композиция
DE60213541D1 (de) Discodermolid-Analoga und ihre pharmazeutische Verwendung
ATE342906T1 (de) Tumorhemmende cerverbindungen
RU2004103481A (ru) С-2-метилированные производные паклитаксела для применения в качестве противоопухолевых агентов
TH51266A (th) C-4 คาร์บอเนทแทกเซน